Keros Therapeutics, Inc. · NASDAQ:KROS
JPMorgan Chase & Co reported a 6.30% stake in Keros Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 2, 2025
JPMorgan Chase & Co reported a 6.30% stake in Keros Therapeutics, Inc., 2,587,146 shares, as a passive investor on Mar 31, 2025. Filed May 2, 2025 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 2,587,146
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 6.30% | 2,587,146 |
Source
Related
- Keros Therapeutics, Inc.
- JPMorgan Chase & Co
- Keros Therapeutics, Inc. shareholders
- Schedule 13G/A · JPMorgan Chase & Co · May 5, 2025
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Newton Charles W. · Aug 20, 2026
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026